Vascular Biogenics Earnings Preview
Portfolio Pulse from Benzinga Insights
Vascular Biogenics (NASDAQ:VBLT) is set to release its latest quarterly earnings report on Friday, 2023-05-26, with analysts estimating an EPS of $-0.15. The company's historical earnings performance shows mixed results, and its stock is down 89.01% over the last 52-week period.
May 25, 2023 | 2:11 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Vascular Biogenics is set to release its quarterly earnings report on 2023-05-26, with an estimated EPS of $-0.15. The stock is down 89.01% over the last 52 weeks.
The upcoming earnings report could have a short-term impact on VBLT's stock price. However, given the mixed historical earnings performance and the stock's significant decline over the last 52 weeks, it is difficult to predict the direction of the stock price based solely on the earnings report. Therefore, the score is neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100